Refine by
Patient Handling Articles & Analysis
31 news found
SeqOne today announced the results of a long-standing research collaboration with Pr. Laurent Mesnard, Co-Director of the French National center for Thrombotic MicroAngiopathies (CNR-MAT), aimed at improving the diagnosis and management of patients suspected of suffering from thrombotic microangiopathies and atypical Hemolytic syndrome (aHUS). The program involved using Oxford Nanopore’s ...
Or should they have an option to opt-out? Opt-in consent requires patients to actively check “yes” to anonymized medical data sharing, whereas opt-out provides an optionality for patients to say “no” to have their data removed from data sharing. ...
For VisionQuest’s vice president and principal investigator Vinayak Joshi (PhD), the journey from idea to commercial product has led him halfway around the world. Dr. Joshi recently traveled to Malawi, Kenya, Nigeria, and Ghana as part of his efforts to commercialize ASPIRE, his device for the detection and diagnosis of malarial retinopathy. While in Africa, he met with leaders in ...
Babson Diagnostics, a science-first, health care technology company, and BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced the expansion of a strategic partnership to move blood sample collection into new care settings, including enabling patients to collect blood samples at home for diagnostic testing. Since 2019, the ...
Terumo Aortic today announced that the US Food and Drug Administration (FDA) has granted approval of the Thoraflex Hybrid Frozen Elephant Trunk (FET) device for commercial sale in the United States for the treatment of patients with complex aortic arch disease. Thoraflex Hybrid is the first of its kind device used in Frozen Elephant Trunk (FET) repair in the United States and was granted ...
“What has hindered the ongoing evolution of cell-based therapies is the reliance on slower, more expensive, one-batch-per-patient autologous approaches and scale-limited manufacturing processes. ...
ReWalk Robotics, Ltd. (Nasdaq: RWLK) ("ReWalk" or the "Company"), a manufacturer of robotic medical devices for individuals with lower limb disabilities, today announced its ReStore Soft Exo-Suit was the subject of a recent Medtech Innovation Briefing (MIB) by the UK's National Institute for Health and Care Excellence (NICE). These briefings are designed to support National Health Services (NHS) ...
AcuPebble SA100 is clinically equivalent to cardiorespiratory polygraphy for the automated diagnosis of obstructive sleep apnea (OSA) at home, a paper published in the BMJ Open has revealed. A powered clinical trial conducted by the Royal Free Hospital in London demonstrated both the accuracy and usability of the small device, which has the potential to open more efficient patient pathways for ...
As new coronavirus variants continue to mutate and spread, the growth in demand for infection prevention solutions using UV-C light is projected to reach $18.94 billion by 2030, witnessing an annual growth rate of 59.7% from 2021 to 2030. Further fueling the demand is the rise in hospital acquired infections (HAIs) that globally cause more fatalities due to the increase in antibiotic resistance ...
USA. Ergotrics is pleased to present the world’s first inflatable prone ventilation support to improve prone ventilation in the Intensive Care Unit (ICU). Scientific studies highlight the benefits of optimized PEEP and long recruitment for ARDS patients ventilated in alternating supine/prone position, but it is one of the most challenging and ergonomically demanding position changes for ...
In a world with increasing labor shortages and a growing ageing population, demand for service robots that can assist companies and institutions is growing. This is why Blue Ocean Robotics, Europe’s largest manufacturer of service robots, has now strengthened its financial muscle, enabling the company to roll out its sustainable mobile robot solutions all over the world. Service robots are ...
Lixte Biotechnology Holdings, Inc. (Nasdaq: LIXT) announced that the National Cancer Institute (NCI) has resumed enrolling patients into their pharmacologic study of the ability of Lixte’s lead compound, LB-100, to enter the brain and penetrate recurrent, malignant brain tumors, in patients where surgical removal of their cancer is indicated. After enrolling two patients in the study, ...
Developing Ethical AI-Supported Healthcare Robots The former study is led by Franziska Kirstein, who aims to investigate how healthcare robotics companies handle ethical issues in the implementation of AI features. Her presentation is based on the PTR Robots case and has received funding from NGI Explorers. ...
Key data from the first-in-human FORTITUDE trial shows that a single cycle of intravenous (IV) NG-350A drives dose-dependent increases in specific inflammatory biomarkers, consistent with the mechanism of the encoded anti- CD40 agonist. IV dosing of NG-350A led to elevations in IL-12, IFNγ and IL-17 that were higher and sustained for longer than those reported for systemic CD40 agonists. ...
Sunday 5th September our PTR Robot was featured on Danish TV, about the robot being deployed at the new hospital, Region Sealand University Hospital Koege. To see video, please click here The public was invited to an open hospital event in Koege at the Region Zealand University Hospital. The 600 million euro development project includes a brand new 140.000 m2 hospital building with 789 single ...
In the last couple of years, the corona virus has caused a huge impact all across Europe. UVD Robots and Blue Ocean Robotics - the manufacturer of the autonomous disinfecting robot equipped with UV-C light - was selected by the European Commission, as a supplier for its autonomous disinfection robots to European Union hospitals in the fight against SARS-CoV-2 known as Coronavirus. Each year ...
Today, Blue Ocean Robotics the manufacturer of UVD Robots for autonomous UV-C disinfection announced that it was selected by ISS World Services, one of the world’s leading global workplace experience and facility management companies, to provide autonomous robots for disinfection as part of ISS’ global offering. The agreement allows ISS to offer hospital-grade disinfection to its ...
This is the first medical wristwatch to receive medical regulatory approval for beat by beat heart rate monitoring and A-Fib detection with ECG accuracy The approval allows the company to start selling its medical watch to patients in Israel requiring continuous heart rate monitoring. This enables early detection of Atrial Fibrillation, which can cause severe heart problems, strokes and ...
BioTrace Medical, Inc., the leader in innovative temporary pacing technology, today announced the company’s key activities at the Annual Transcatheter Valve Therapy Structural Heart Summit (TVT 2019), which will take place June 12-15 at the Sheraton Grand Chicago. The company’s Tempo Temporary Pacing Lead will be featured in a symposium titled “Improving Safety & Reducing ...
A complete redesign of the T-Stat was launched in 2020. New features included a sleek and strong exterior of powder coated metal, framed with a soft plastic bumper to prevent any damage in the hospital environment. Battery back-up was added to make patient ambulation and transfer seemless and without any interruption in patient data. WiFi access has been added to accommodate hospitals and labs ...